Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2

← catalyst calendar

NCT04514861 · readout in 223 d

Sponsored by Profusa, Inc. (industry) · PFSA — their whole pipeline →. With National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI).

Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Basic science
Enrollment
53estimated
Sites
3
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2020-12-18actualWhen the study began enrolling
Primary completion2027-03-30estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completion2028-03-30estimatedThe whole study's end, after follow-up
First posted2020-08-17actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-11-12actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Peripheral Artery Disease

Intervention

  • Device: Wireless Lumee Oxygen Platform

Primary outcome

what the primary-completion date above is the date OF
Correlation of subcutaneous oxygen dynamics measured by the Wireless Lumee Oxygen Platform and a TcPO2 device in the arm
measured At 2 days (±1 day) after injection and at 3 months (±14 days) after injection

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · PFSA's whole pipeline · Catalyst calendar · Every registered study · What changed